Selected research
Industry Research
Cyclic Peptide Compounds Industry Research Report 2026
Market perspective
The global Cyclic Peptide Compounds market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cyclic Peptide Compounds is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cyclic Peptide Compounds is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cyclic Peptide Compounds is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cyclic Peptide Compounds include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cyclic Peptide Compounds market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Cyclic Peptide Compounds.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cyclic Peptide Compounds Market by Company
Apellis Pharmaceuticals
Bachem
Bicycle Therapeutics
Merck
Roche (Chugai Pharmabody Research)
Pfizer
Novartis
Biopharma PEG Scientific
Cyclic Peptide Compounds Segment by Type
Synthetic Cyclic Peptide
Natural Cyclic Peptide
Cyclic Peptide Compounds Segment by Application
Biopharmaceutical
Scientific Research
Environmental Protection
Others
Cyclic Peptide Compounds Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclic Peptide Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclic Peptide Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclic Peptide Compounds.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyclic Peptide Compounds by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyclic Peptide Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic Cyclic Peptide
- Natural Cyclic Peptide
Applications
- Biopharmaceutical
- Scientific Research
- Environmental Protection
- Others
Companies covered
- Apellis Pharmaceuticals
- Bachem
- Bicycle Therapeutics
- Merck
- Roche (Chugai Pharmabody Research)
- Pfizer
- Novartis
- Biopharma PEG Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cyclic Peptide Compounds by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Synthetic Cyclic Peptide
- 2.2.3 Natural Cyclic Peptide
- 2.3 Cyclic Peptide Compounds by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Biopharmaceutical
- 2.3.3 Scientific Research
- 2.3.4 Environmental Protection
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Cyclic Peptide Compounds Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Cyclic Peptide Compounds Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cyclic Peptide Compounds Production by Manufacturers (2021-2026)
- 3.2 Global Cyclic Peptide Compounds Production Value by Manufacturers (2021-2026)
- 3.3 Global Cyclic Peptide Compounds Average Price by Manufacturers (2021-2026)
- 3.4 Global Cyclic Peptide Compounds Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyclic Peptide Compounds Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Cyclic Peptide Compounds Manufacturers, Product Type & Application
- 3.7 Global Cyclic Peptide Compounds Manufacturers Established Date
- 3.8 Global Cyclic Peptide Compounds Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Apellis Pharmaceuticals
- 4.1.1 Apellis Pharmaceuticals Cyclic Peptide Compounds Company Information
- 4.1.2 Apellis Pharmaceuticals Cyclic Peptide Compounds Business Overview
- 4.1.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Apellis Pharmaceuticals Product Portfolio
- 4.1.5 Apellis Pharmaceuticals Recent Developments
- 4.2 Bachem
- 4.2.1 Bachem Cyclic Peptide Compounds Company Information
- 4.2.2 Bachem Cyclic Peptide Compounds Business Overview
- 4.2.3 Bachem Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Bachem Product Portfolio
- 4.2.5 Bachem Recent Developments
- 4.3 Bicycle Therapeutics
- 4.3.1 Bicycle Therapeutics Cyclic Peptide Compounds Company Information
- 4.3.2 Bicycle Therapeutics Cyclic Peptide Compounds Business Overview
- 4.3.3 Bicycle Therapeutics Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Bicycle Therapeutics Product Portfolio
- 4.3.5 Bicycle Therapeutics Recent Developments
- 4.4 Merck
- 4.4.1 Merck Cyclic Peptide Compounds Company Information
- 4.4.2 Merck Cyclic Peptide Compounds Business Overview
- 4.4.3 Merck Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Merck Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Roche (Chugai Pharmabody Research)
- 4.5.1 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Company Information
- 4.5.2 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Business Overview
- 4.5.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Roche (Chugai Pharmabody Research) Product Portfolio
- 4.5.5 Roche (Chugai Pharmabody Research) Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Cyclic Peptide Compounds Company Information
- 4.6.2 Pfizer Cyclic Peptide Compounds Business Overview
- 4.6.3 Pfizer Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Pfizer Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Cyclic Peptide Compounds Company Information
- 4.7.2 Novartis Cyclic Peptide Compounds Business Overview
- 4.7.3 Novartis Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Novartis Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Biopharma PEG Scientific
- 4.8.1 Biopharma PEG Scientific Cyclic Peptide Compounds Company Information
- 4.8.2 Biopharma PEG Scientific Cyclic Peptide Compounds Business Overview
- 4.8.3 Biopharma PEG Scientific Cyclic Peptide Compounds Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Biopharma PEG Scientific Product Portfolio
- 4.8.5 Biopharma PEG Scientific Recent Developments
5 Global Cyclic Peptide Compounds Production by Region
- 5.1 Global Cyclic Peptide Compounds Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cyclic Peptide Compounds Production by Region: 2021-2032
- 5.2.1 Global Cyclic Peptide Compounds Production by Region: 2021-2026
- 5.2.2 Global Cyclic Peptide Compounds Production Forecast by Region (2027-2032)
- 5.3 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Cyclic Peptide Compounds Production Value by Region: 2021-2032
- 5.4.1 Global Cyclic Peptide Compounds Production Value by Region: 2021-2026
- 5.4.2 Global Cyclic Peptide Compounds Production Value Forecast by Region (2027-2032)
- 5.5 Global Cyclic Peptide Compounds Market Price Analysis by Region (2021-2026)
- 5.6 Global Cyclic Peptide Compounds Production and Value, YOY Growth
- 5.6.1 North America Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
6 Global Cyclic Peptide Compounds Consumption by Region
- 6.1 Global Cyclic Peptide Compounds Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cyclic Peptide Compounds Consumption by Region (2021-2032)
- 6.2.1 Global Cyclic Peptide Compounds Consumption by Region: 2021-2026
- 6.2.2 Global Cyclic Peptide Compounds Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cyclic Peptide Compounds Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cyclic Peptide Compounds Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cyclic Peptide Compounds Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Cyclic Peptide Compounds Production by Type (2021-2032)
- 7.1.1 Global Cyclic Peptide Compounds Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Cyclic Peptide Compounds Production Market Share by Type (2021-2032)
- 7.2 Global Cyclic Peptide Compounds Production Value by Type (2021-2032)
- 7.2.1 Global Cyclic Peptide Compounds Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Cyclic Peptide Compounds Production Value Market Share by Type (2021-2032)
- 7.3 Global Cyclic Peptide Compounds Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Cyclic Peptide Compounds Production by Application (2021-2032)
- 8.1.1 Global Cyclic Peptide Compounds Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Cyclic Peptide Compounds Production Market Share by Application (2021-2032)
- 8.2 Global Cyclic Peptide Compounds Production Value by Application (2021-2032)
- 8.2.1 Global Cyclic Peptide Compounds Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Cyclic Peptide Compounds Production Value Market Share by Application (2021-2032)
- 8.3 Global Cyclic Peptide Compounds Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Cyclic Peptide Compounds Value Chain Analysis
- 9.1.1 Cyclic Peptide Compounds Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Cyclic Peptide Compounds Production Mode & Process
- 9.2 Cyclic Peptide Compounds Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cyclic Peptide Compounds Distributors
- 9.2.3 Cyclic Peptide Compounds Customers
10 Global Cyclic Peptide Compounds Analyzing Market Dynamics
- 10.1 Cyclic Peptide Compounds Industry Trends
- 10.2 Cyclic Peptide Compounds Industry Drivers
- 10.3 Cyclic Peptide Compounds Industry Opportunities and Challenges
- 10.4 Cyclic Peptide Compounds Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst